NCT04221945 2026-02-20
KEYNOTE-A18
Merck Sharp & Dohme LLC
Phase 3 Completed
Clinical Trials
12 trialsNCT05570422 2025-09-11
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Kortuc, Inc.
Phase 1 Not yet recruiting
NCT04634877 2025-06-09
KEYNOTE-B21
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT03290534 2025-04-04
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
CivaTech Oncology
Phase 2 Recruiting
NCT03830866 2024-07-26
CALLA
AstraZeneca
Phase 3 Completed
NCT01851772 2021-01-12
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Xoft, Inc.
Phase NA Completed
NCT01017549 2020-08-13
Post Market Study Using the Xoft Axxent System
Xoft, Inc.
Phase NA Completed
NCT01374087 2019-09-18
ANABRAQ
Ipsen
Phase 2 Terminated
NCT00770822 2019-04-10
SetPace
SonaCare Medical
Phase NA Unknown
NCT01301612 2014-07-14
Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)
Eurofarma Laboratorios S.A.
Phase 2 Withdrawn
NCT01045187 2012-08-01
Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer
Xoft, Inc.
Phase NA Completed
NCT00191100 2009-08-11
Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix
Eli Lilly and Company
Phase 3 Completed